Medical Affairs Lead - GU/GYN at AstraZeneca in UK - London
- Company: AstraZeneca
- Location: UK - London
- Posted: Sep 23, 2026
- Type: Full time
- Experience: 6+ years
- Visa sponsorship available
Overview
Join our Oncology Business Unit as a Medical Affairs Lead. You will lead the medical input to business strategic and operational planning for indications within our GU and GYN Oncology portfolios, including the development of the Medical Affairs plans; Lead delivery of clinical insight, customer foc…
Job description
- Join our Oncology Business Unit as a Medical Affairs Lead. You will lead the medical input to business strategic and operational planning for indications within our GU and GYN Oncology portfolios, including the development of the Medical Affairs plans; Lead delivery of clinical insight, customer focus and clinical governance into Medical and Business Unit objectives. You will also deliver Indication Brand objectives as outlined in Brand Medical Plans and develop and deliver pre-launch and peri-launch medical plans and activities.
Responsibilities
- In this role, you will provide strong matrix leadership to the Therapy Area Medical Team, contributing to a team environment that supports innovation, coaching and mentoring the TA medical team to drive excellence in skill and performance.
- You will develop and maintain scientific relationships with key customers, leverage medical insight from internal and external customers into local evidence generation plans to support value propositions for the UK; Provide the medical direction for all brand related activities, and provide expert medical input into key Market Access activities.
- You will also support AZ OBU to ensure that all activities conducted are within the appropriate regulatory and compliance frameworks.
Requirements
- Proven Track record of leadership across medical affairs, specifically demonstrable strategic thinking, communication and engagement and leadership and collaboration skills
- Prior launch experience, in a Medical Affairs role
- Experience in oncology medicines
- Extensive patient and customer insight through experience of working with the NHS (or a similar national health care system)
- Proven ability to interact with external customers
- Degree or equivalent experience in related scientific field
- Demonstrated ability to form strong cross functional partnerships
- Registered Physician (preferably GMC) or Pharmacist (General Pharmaceutical Council)
- Member/Fellow of a Royal College or the Royal Pharmaceutical Society
- Higher Degree in Oncology (e.g. PhD and MSc Oncology)
- Extensive experience in oncology – solid tumours, and especially GYN/GU cancers
- Hold or successfully acquire Nominated Signatory status
- Proven expertise in the ABPI Code of Practice
Skills
Required
- Strategic thinking
- Communication and engagement
- Leadership and collaboration
- Patient and customer insight
- Cross functional partnerships
Preferred
- Nominated Signatory status
- ABPI Code of Practice expertise
About AstraZeneca
As Leaders within Oncology, our ability to effectively and creatively market our products and lead our business has a meaningful impact. It powers our business to lead the way for the industry and to impact more lives, making a difference to those living with cancer. Working across our broad and innovative pipeline, we fuse our business mindset and scientific knowledge to bring transformative medicines and novel treatments to those who need it the most. At AstraZeneca UK, we are committed to delivering against three missions: • Accelerating the position of the UK as a global centre of excellence in life sciences • Redefining healthcare through fast and equitable access to the most effective medicines, high quality care • Delivering sustainable leadership that prioritises healthy people, society and planet Our head office in Pancras Square offers us the strongest possible platform to transform the lives of patients, as the country’s leading biopharmaceutical company. It brings AstraZeneca UK closer to our customers, partners and collaborators in the UK’s healthcare environment, as well as develop greater collaboration with the wider AstraZeneca footprint.